Transport and metabolism of (±)-praeruptorin A in Caco-2 cell monolayers

Xenobiotica

Volumn 41, Issue 1, 2011, Pages 71-81

  Jing, W H ^a   Song, Y L ^a   Yan, R ^a   Bi, H C ^a,b   Li, P T ^c   Wang, Y T ^a,c  

^a University of Macau   (Macao)

^b SUN YAT SEN UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

( ) Praeruptorin A; Caco 2 cells; Enantioselectivity; Hydrolysis; Metabolism; Transport

Indexed keywords

INDOMETACIN; LICOPYRANOCOUMARIN; OUABAIN; PRAERUPTORIN A; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CANCER CELL CULTURE; CLINICAL EVALUATION; COLON CARCINOMA; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CYTOTOXICITY; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; QUALITY CONTROL;

EID: 78650181023     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498254.2010.526653     Document Type: Article

References (32)

1. Chang TH, Liu XY, Zhang XH, Xing J, Wang HL. (2003). Effects of Peucedanum Praeruptorum Dunn and dl-Praeruptorin A on IL-6 Level and Fas, bax, bcl-2 protein expressions in ischemiareperfusion myocardium of rats. Zhongguo Yi Ke Da Xue Xue Bao 32: 1-6.
2. Drayer DE. (1986). Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview. Clin Pharmacol Ther 40:125-133.
3. Dickman KG, Hempson SJ, Anderson J, Lippe S, Zhao L, Burakoff R, Shaw RD. (2000). Rotavirus alters paracellular permeability and energy metabolism in Caco-2 cells. Am J Physiol Gastrointest Liver Physiol 279:G757-G766.
4. Engman HA, Lennernäs H, Taipalensuu J, Otter C, Leidvik B, Artursson P. (2001). CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies. J Pharm Sci 90:1736-1751.
5. Feng WY, Li JM, Zhang KY. (1998). Effect of Pd-Ia on elctrophysiological proterties of guinea pig wenticular cell. Zhongguo Yao Xue Za Zhi 33: 660-662.
6. Hunter J, Hirst BH, Simmons NL. (1993). Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharm Res 10:743-749.
7. Imai T, Imoto M, Sakamoto H, Hashimoto M. (2005). IDentification of esterases expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption. Drug Metab Dispos 33:1185-1190.
8. Imai T, Taketani M, Shii M, Hosokawa M, Chiba K. (2006). Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine. Drug Metab Dispos 34:1734-1741.
9. Mei L, Nicoletti M, Battinelli L, Mazzanti G. (2001). Isolation of praeruptorins A and B from Peucedanum praeruptorum Dunn., and their general pharmacological evaluation in comparison with extracts of drug. Il Farmaco 56: 417-420.
10. Ogihara T, Tamai I, Takanaga H, Sai Y, Tsuji A. (1996). Stereoselective and carrier-mediated transport of monocarboxylic acids across Caco-2 cells. Pharm Res 13:1828-1832.
11. Petri N, Tannergren C, Rungstad D, Lennernäs H. (2004). Transport characteristics of fexofenadine in the Caco-2 cell model. Pharm Res 21:1398-1404.
12. 2+, Mg(2+)-ATPase activity in renovascular hypertensive rats. Yao Xue Xue Bao 37:401-404.
13. Ruan JQ, Leong WI, Yan R, Wang YT. (2010). Characterization of metabolism and in vitro permeability study of notoginsenoside R1 from Radix notoginseng. J Agric Food Chem 58:5770-5776.
14. Sun D, Lennernas H, Welage LS, Barnett JL, Landowski CP, Foster D, Fleisher D, Lee KD, Amidon GL. (2002). Comparison of human duoDenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharm Res 19:1400-1416.
15. Suzuki H, Sugiyama Y. (2000). Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur J Pharm Sci 12:3-12.
16. Taipalensuu J, Törnblom H, Lindberg G, Einarsson C, Sjöqvist F, Melhus H, Garberg P, Sjöström B, Lundgren B, Artursson P. (2001). Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 299:164-170.
17. Tantishaiyakul V, Wiwattanawongsa K, Pinsuwan S, Kasiwong S, Phadoongsombut N, Kaewnopparat S, Kaewnopparat N, Rojanasakul Y. (2002). Characterization of mefenamic acid-guaiacol ester: Stability and transport across Caco-2 cell monolayers. Pharm Res 19:1013-1018.
18. Takai S, Matsuda A, Usami Y, Adachi T, Sugiyama T, Katagiri Y, Tatematsu M, Hirano K. (1997). Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver. Biol Pharm Bull 20:869-873.
19. Tang M, Mukundan M, Yang J, Charpentier N, LeCluyse EL, Black C, Yang D, Shi D, Yan B. (2006). Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol. J Pharmacol Exp Ther 319:1467-1476.
20. Teruko I, Masumi L, Hisae S, Mitsuru H. (2005). IDentification of esterases expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption. Drug Metab Dispos 33: 1185-1190.
21. The state pharmacopoeia commission of P. R. China. (2010). Peucedani Radix. In: Pharmacopoeia of people's republic of China, Beijing, China: Chemical industry press. Vol I:187.
22. Violini S, Sharma V, Prior JL, Dyszlewski M, Worms DP. (2002). EviDence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: Lack of correlation with heparan sulfate. BioChemistry 41: 12652-12661.
23. Walgren RA, Walle UK, Walle T. (1998). Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem Pharmacol 55:1721-1727.
24. Wang LJ, Li JM, Chang TH, Hao LY. (1995). Effect of dl-praeruptorin A on delayed outward potassium current in single ventricular cell of guunea pig. Chinese Journal of pharmacology and toxicology 9:192-195.
25. Wang Y, Yan SX, Jia L, Tian L, Tu X, Lu JX. (2006). Effect of Pd-Ia on angiotensin II induced c-Jun protein expression in cadiocytes. China Pharmacist 9: 685-687.
26. Wei EH, Rao MR, Chen XY, Fan LM, Chen Q. (2002). Inhibitory effects of praeruptorin C on cattle aortic smooth muscle cell proliferation. Acta Pharmacol Sin 23:129-132.
27. Wu XL, Kong LY, Min ZD. (2002). Studies of structure modification of (+)-Praeruptorin A. Acta Pharm Sin 37: 527-534.
28. Yee S. (1997). In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth. Pharm Res 14:763-766.
29. Xu Z, Wang X, Dai Y, Kong L, Wang F, Xu H, Lu D, Song J, Hou Z. (2010). (+/-)-Praeruptorin A enantiomers exert distinct relaxant effects on isolated rat aorta rings dependent on endothelium and nitric oxide synthesis. Chem Biol Interact 186:239-246.
30. Zhang SL, Li JM, Xiao QH, Wu AH, Zhao Q, Yang GR, Zhang KY. (2001). Effect of dl-praeruptorin A on ATP sensitive potassium channels in human cortical neurons. Acta Pharmacol Sin 22:813-816.
31. Zhao NC, Jin WB, Zhang XH, Guan FL, Sun YB, Adachi H, Okuyama T. (1999). Relaxant effects of pyranocoumarin compounds isolated from a Chinese medical plant, Bai-Hua Qian-Hu, on isolated rabbit tracheas and pulmonary arteries. Biol Pharm Bull 22:984-987.
32. Zhu HJ, Wang JS, Markowitz JS, DonoVan JL, Gibson BB, Gefroh HA, DeVane CL. (2006). Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana. J Pharmacol Exp Ther 317: 850-857.